188 related articles for article (PubMed ID: 36385461)
1. Ethnic-specificity, evolution origin and deleteriousness of Asian BRCA variation revealed by over 7500 BRCA variants derived from Asian population.
Qin Z; Li J; Tam B; Sinha S; Zhao B; Bhaskaran SP; Huang T; Wu X; Chian JS; Guo M; Kou SH; Lei H; Zhang L; Wang X; Lagniton PNP; Xiao F; Jiang X; Wang SM
Int J Cancer; 2023 Mar; 152(6):1159-1173. PubMed ID: 36385461
[TBL] [Abstract][Full Text] [Related]
2. Germline variation in BRCA1/2 is highly ethnic-specific: Evidence from over 30,000 Chinese hereditary breast and ovarian cancer patients.
Bhaskaran SP; Chandratre K; Gupta H; Zhang L; Wang X; Cui J; Kim YC; Sinha S; Jiang L; Lu B; Wu X; Qin Z; Huang T; Wang SM
Int J Cancer; 2019 Aug; 145(4):962-973. PubMed ID: 30702160
[TBL] [Abstract][Full Text] [Related]
3. Using Portuguese BRCA pathogenic variation as a model to study the impact of human admixture on human health.
Andaluz S; Zhao B; Sinha S; Lagniton PNP; Costa DA; Ding X; Brito M; Wang SM
BMC Genomics; 2024 Apr; 25(1):416. PubMed ID: 38671360
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and spectrum of BRCA germline variants in mainland Chinese familial breast and ovarian cancer patients.
Kim YC; Zhao L; Zhang H; Huang Y; Cui J; Xiao F; Downs B; Wang SM
Oncotarget; 2016 Feb; 7(8):9600-12. PubMed ID: 26848529
[TBL] [Abstract][Full Text] [Related]
5. Ethnic-specific
Bhaskaran SP; Huang T; Rajendran BK; Guo M; Luo J; Qin Z; Zhao B; Chian J; Li S; Wang SM
J Med Genet; 2021 Nov; 58(11):752-759. PubMed ID: 32963034
[TBL] [Abstract][Full Text] [Related]
6. BRCA germline mutations in an unselected nationwide cohort of Chinese patients with ovarian cancer and healthy controls.
Li A; Xie R; Zhi Q; Deng Y; Wu Y; Li W; Yang L; Jiao Z; Luo J; Zi Y; Sun G; Zhang J; Shi Y; Liu J
Gynecol Oncol; 2018 Oct; 151(1):145-152. PubMed ID: 30078507
[TBL] [Abstract][Full Text] [Related]
7. Germline BRCA mutations in Asian patients with pancreatic adenocarcinoma: a prospective study evaluating risk category for genetic testing.
Lee K; Yoo C; Kim KP; Park KJ; Chang HM; Kim TW; Lee JL; Lee W; Lee SS; Park DH; Song TJ; Seo DW; Lee SK; Kim MH; Shin SH; Hwang DW; Song KB; Lee JH; Kim SC; Ryoo BY
Invest New Drugs; 2018 Feb; 36(1):163-169. PubMed ID: 28782087
[TBL] [Abstract][Full Text] [Related]
8. Mutations in BRCA-related breast and ovarian cancer in the South African Indian population: A descriptive study.
Combrink HM; Oosthuizen J; Visser B; Chabilal N; Buccimazza I; Foulkes WD; van der Merwe NC
Cancer Genet; 2021 Nov; 258-259():1-6. PubMed ID: 34218100
[TBL] [Abstract][Full Text] [Related]
9. High prevalence of deleterious BRCA1 and BRCA2 germline mutations in arab breast and ovarian cancer patients.
Alhuqail AJ; Alzahrani A; Almubarak H; Al-Qadheeb S; Alghofaili L; Almoghrabi N; Alhussaini H; Park BH; Colak D; Karakas B
Breast Cancer Res Treat; 2018 Apr; 168(3):695-702. PubMed ID: 29297111
[TBL] [Abstract][Full Text] [Related]
10. Germline variants profiling of BRCA1 and BRCA2 in Chinese Hakka breast and ovarian cancer patients.
Zhang Y; Wu H; Yu Z; Li L; Zhang J; Liang X; Huang Q
BMC Cancer; 2022 Aug; 22(1):842. PubMed ID: 35918668
[TBL] [Abstract][Full Text] [Related]
11. Human
Li J; Zhao B; Huang T; Qin Z; Wang SM
Life Sci Alliance; 2022 May; 5(5):. PubMed ID: 35165121
[No Abstract] [Full Text] [Related]
12. Prevalence of
Dong H; Chandratre K; Qin Y; Zhang J; Tian X; Rong C; Wang N; Guo M; Zhao G; Wang SM
J Med Genet; 2021 Aug; 58(8):565-569. PubMed ID: 32467295
[TBL] [Abstract][Full Text] [Related]
13.
Chian J; Sinha S; Qin Z; Wang SM
Front Mol Biosci; 2021; 8():685174. PubMed ID: 34235180
[No Abstract] [Full Text] [Related]
14. Prevalence of specific and recurrent/founder pathogenic variants in BRCA genes in breast and ovarian cancer in North Africa.
ElBiad O; Laraqui A; El Boukhrissi F; Mounjid C; Lamsisi M; Bajjou T; Elannaz H; Lahlou AI; Kouach J; Benchekroune K; Oukabli M; Chahdi H; Ennaji MM; Tanz R; Sbitti Y; Ichou M; Ennibi K; Badaoui B; Sekhsokh Y
BMC Cancer; 2022 Feb; 22(1):208. PubMed ID: 35216584
[TBL] [Abstract][Full Text] [Related]
15. Genetic screening results of individuals with high risk BRCA-related breast/ovarian cancer in Trakya region of Turkey.
Demir S; Tozkir H; Gurkan H; Atli EI; Yalcintepe S; Atli E; Sezer YA; Eker D; Tuncbilek N; Tastekin E; Ozen Y; Cicin I
J BUON; 2020; 25(3):1337-1347. PubMed ID: 32862574
[TBL] [Abstract][Full Text] [Related]
16. Full-exon pyrosequencing screening of BRCA germline mutations in Mexican women with inherited breast and ovarian cancer.
Vaca-Paniagua F; Alvarez-Gomez RM; Fragoso-Ontiveros V; Vidal-Millan S; Herrera LA; Cantú D; Bargallo-Rocha E; Mohar A; López-Camarillo C; Pérez-Plasencia C
PLoS One; 2012; 7(5):e37432. PubMed ID: 22655046
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive profiling of BRCA1 and BRCA2 variants in breast and ovarian cancer in Chinese patients.
Gao X; Nan X; Liu Y; Liu R; Zang W; Shan G; Gai F; Zhang J; Li L; Cheng G; Song L
Hum Mutat; 2020 Mar; 41(3):696-708. PubMed ID: 31825140
[TBL] [Abstract][Full Text] [Related]
18. Retrospective reinterpretation and reclassification of BRCA1/2 variants from Chinese population.
Li D; Shi Y; Li A; Cao D; Su H; Yang H; Zhi Q; Yang Y; Lan Z; Zhou T; You X; Hu G
Breast Cancer; 2020 Nov; 27(6):1158-1167. PubMed ID: 32566972
[TBL] [Abstract][Full Text] [Related]
19. BRCA1 and BRCA2 unclassified variants and missense polymorphisms in Algerian breast/ovarian cancer families.
Cherbal F; Salhi N; Bakour R; Adane S; Boualga K; Maillet P
Dis Markers; 2012; 32(6):343-53. PubMed ID: 22684231
[TBL] [Abstract][Full Text] [Related]
20.
Kharel S; Shrestha S; Yadav S; Shakya P; Baidya S; Hirachan S
J Int Med Res; 2022 Jan; 50(1):3000605211070757. PubMed ID: 35000471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
